Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the β-catenin gene

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Oncogene

• Publication date

  2001-09-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1204825PMID 11593404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autosomal dominant polycystic kidney disease.

  2010cited by this paper
• Hepatomegaly in Transgenic Mice Expressing an Oncogenic Form of β-Catenin

  2001cited by this paper
• Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.

  2001cited by this paper
• Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus.

  2000cited by this paper
• Subcellular localization of aldolase B

  2000cited by this paper
• Cardiac defects and renal failure in mice with targeted mutations in Pkd2

  2000cited by this paper
• T cell factor-activated transcription is not sufficient to induce anchorage-independent growth of epithelial cells expressing mutant beta-catenin.

  1999cited by this paper
• Peptides from the PKD repeats of polycystin, the PKD1 gene product, modulate pattern formation in the developing kidney.

  1999cited by this paper
• Peptides from the PKD repeats of polycystin, the PKD1 gene product, modulate pattern formation in the developing kidney.

  1999cited by this paper
• Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue.

  1999cited by this paper
• Intestinal polyposis in mice with a dominant stable mutation of the β‐catenin gene

  1999cited by this paper
• Wnts as kidney tubule inducing factors.

  1999cited by this paper
• Germinal and somatic mutations in the PKD2 gene of renal cysts in autosomal dominant polycystic kidney disease.

  1999cited by this paper
• Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins.

  1999cited by this paper
• Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

  1999cited by this paper
• Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin.

  1999influential reference
• Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay.

  1999cited by this paper
• The Polycystic Kidney Disease 1 Gene Product Modulates Wnt Signaling*

  1999cited by this paper
• β-Catenin regulates expression of cyclin D1 in colon carcinoma cells

  1999cited by this paper
• A polycystic kidney-disease gene homologue required for male mating behaviour in C. elegans

  1999cited by this paper
• Swelling activation of transport pathways in erythrocytes: effects of Cl-, ionic strength, and volume changes.

  1999cited by this paper
• Nuclear localization of β-catenin and loss of apical brush border actin in cystic tubules of bcl-2 -/- mice.

  1999cited by this paper
• De Novo Hair Follicle Morphogenesis and Hair Tumors in Mice Expressing a Truncated β-Catenin in Skin

  1998cited by this paper
• Epithelial transport in polycystic kidney disease.

  1998cited by this paper
• Identification of c-MYC as a target of the APC pathway.

  1998cited by this paper
• Characterization of the Aldolase B Intronic Enhancer*

  1998cited by this paper
• De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin.

  1998cited by this paper
• Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation

  1997cited by this paper
• PKD1 interacts with PKD2 through a probable coiled-coil domain

  1997cited by this paper
• The molecular basis of embryonic kidney development.

  1997cited by this paper
• Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2.

  1997cited by this paper
• Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD).

  1996cited by this paper
• The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances.

  1996cited by this paper
• Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney.

  1996cited by this paper
• The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.

  1996cited by this paper
• Abnormal postpartum renal development and cystogenesis in the bcl-2 (-/-) mouse.

  1996cited by this paper
• Tissue-specific and Hormonal Regulation of Calbindin-D9K Fusion Genes in Transgenic Mice*

  1996cited by this paper
• PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein

  1996cited by this paper
• Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice.

  1995cited by this paper
• The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains

  1995cited by this paper
• E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton

  1994cited by this paper
• Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4

  1994cited by this paper
• Autosomal dominant polycystic kidney disease.

  1993cited by this paper
• The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins

  1993cited by this paper
• 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO.

  1991cited by this paper
• Reversed polarity of Na(+) -K(+) -ATPase: mislocation to apical plasma membranes in polycystic kidney disease epithelia.

  1991cited by this paper
• Vitamin D-dependent calcium binding proteins: chemistry, distribution, functional considerations, and molecular biology.

  1989cited by this paper
• Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper

• Urinary DKK3 as a biomarker for pediatric CKD progression: a review of current evidence.

  2026cites this paper
• Spatiotemporal distribution of Wnt signaling pathway markers in human congenital anomalies of kidney and urinary tract.

  2025cites this paper
• Signal integrator function of CXXC5 in Cancer

  2025cites this paper
• Glycogen synthase kinase 3β: a key player in progressive chronic kidney disease

  2025cites this paper
• The Role of the PAX Genes in Renal Cell Carcinoma

  2024cites this paper
• Analysis of serum proteomic in cats with polycystic kidney disease-1 gene mutation

  2024cites this paper
• The Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) oncogene is upregulated in cystic epithelial cells revealing a potential new target for polycystic kidney disease

  2024cites this paper
• Mice with renal-specific alterations of stem cell-associated signaling develop symptoms of chronic kidney disease but surprisingly no tumors

  2024cites this paper
• The Role of Wnt Signaling Pathway in Kidney Development

  2023cites this paper
• Polycystin-2 dependent transcriptome reveals early response of autosomal dominant polycystic kidney disease.

  2023cites this paper
• Ameliorating liver disease in an autosomal recessive polycystic kidney disease (ARPKD) mouse model.

  2023cites this paper
• Clinical findings, underlying pathogenetic processes and treatment of vascular dysfunction in autosomal dominant polycystic kidney disease

  2023cites this paper
• The Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) oncogene is upregulated in pre-cystic epithelial cells revealing a new target for polycystic kidney disease

  2023cites this paper
• Transcription factors AP-2α and AP-2β regulate distinct segments of the distal nephron in the mammalian kidney

  2022cites this paper
• Primary cilium in kidney development, function and disease

  2022cites this paper
• The cellular pathways and potential therapeutics of Polycystic Kidney Disease.

  2021cites this paper
• A case of cerebral infarction caused by painless acute aortic dissection in autosomal dominant polycystic kidney disease

  2020cites this paper
• The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease.

  2020cites this paper
• Proteomics and metabolomics studies exploring the pathophysiology of renal dysfunction in autosomal dominant polycystic kidney disease and other ciliopathies.

  2020cites this paper
• Kidney epithelial targeted mitochondrial transcription factor A deficiency results in progressive mitochondrial depletion associated with severe cystic disease.

  2020cites this paper
• The Role of Wnt Signalling in Chronic Kidney Disease (CKD)

  2020cites this paper
• TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease

  2020cites this paper
• Targeting the Wnt signaling pathway: the challenge of reducing scarring without affecting repair

  2020cites this paper
• Regulation of canonical Wnt signalling by ciliary protein MKS1 and Ubiquitin Proteasome System component UBE2E1

  2020cites this paper
• Molecular pathways involved in injury-repair and ADPKD progression.

  2020cites this paper
• AP-2β/KCTD1 Control Distal Nephron Differentiation and Protect against Renal Fibrosis.

  2020cites this paper
• YAP‑mediated crosstalk between the Wnt and Hippo signaling pathways (Review).

  2020cites this paper
• Hepatocyte nuclear factor-1β regulates Wnt signaling through genome-wide competition with β-catenin/lymphoid enhancer binding factor

  2019cites this paper
• Thyroid and renal tumors in patients treated with long-term lithium: case series from a lithium clinic, review of the literature and international pharmacovigilance reports

  2018cites this paper
• Wnt Signaling in Kidney Development and Disease.

  2018cites this paper
• Rosiglitazone affects lumen formation in MDCKII cell through regulating apico-basal polarity.

  2018cites this paper
• Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD.

  2018cites this paper
• c‐Myc is a regulator of the PKD1 gene and PC1‐induced pathogenesis

  2018cites this paper
• &bgr;-catenin ablation exacerbates polycystic kidney disease progression

  2018cites this paper
• Wnt Signaling Pathway in Polycystic Kidney Disease

  2018cites this paper
• Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs

  2017cites this paper
• Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling

  2017cites this paper
• Primary Cilia in Cystic Kidney Disease.

  2017cites this paper
• Ciliary subcompartments and cysto-proteins

  2017cites this paper
• Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease.

  2017cites this paper
• Polycystic kidney disease

  2017cites this paper
• Hippo vs. Crab: tissue‐specific functions of the mammalian Hippo pathway

  2017cites this paper
• Kindlin‑2 promotes clear cell renal cell carcinoma progression through the Wnt signaling pathway.

  2017cites this paper
• Funktionelle Analyse der Histondeacetylase 6 sowie experimentelle Modellierung von Lateralitätsdefekten während der Links-Rechts-Achsenentwicklung von Xenopus laevis und Paracentrotus lividus

  2017cites this paper
• Chapter 17 – Wnt, Notch, and Tubular Pathology

  2016cites this paper
• Jade-1: its structure, regulation and functions in the renal cancer.

  2016cites this paper
• LDL Receptor-Related Protein 6 Modulates Ret Proto-Oncogene Signaling in Renal Development and Cystic Dysplasia.

  2016cites this paper
• Hippo signaling in the kidney: the good and the bad.

  2016cites this paper
• Acute kidney injury induces hallmarks of polycystic kidney disease.

  2016cites this paper
• Structural and Biochemical Characterization of Ciliary Targeting Complexes Reveals a Novel Dual Effector Bound Mechanism for the Rab11:GTP - FIP3 - Rabin8 Module

  2016cites this paper
• Prokineticin receptor 1 is required for mesenchymal‐epithelial transition in kidney development

  2016cites this paper
• Cilia in autophagy and cancer

  2016cites this paper
• Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis.

  2016cites this paper
• Six2creFrs2α knockout mice are a novel model of renal cystogenesis

  2016cites this paper
• Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes

  2016cites this paper
• Overview of Nephronophthisis : A Genetically Heterogeneous Ciliopathy

  2016cites this paper
• Inflammation and Fibrosis in ADPKD.

  2016cites this paper
• Polycystin-1 and Gα12 regulate the cleavage of E-cadherin in kidney epithelial cells.

  2015cites this paper
• LRP5 variants may contribute to ADPKD

  2015cites this paper
• Distal 10q trisomy with copy number gain in chromosome region 10q23.1–10q25.1: the Wnt signaling pathway is the most pertinent to the gene content in the region of copy number gain: a case report

  2015cites this paper
• Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damage.

  2015cites this paper
• The extra ciliary roles of Meckel-Gruber syndrome proteins

  2015cites this paper
• Molecular basis of hereditary cystic kidney diseases

  2015cites this paper
• Cell and developmental stage specific role of Dicer1 in the lung epithelium

  2015cites this paper
• Mise en évidence et caractérisation de nouveaux gènes impliqués dans les ciliopathies rénales

  2015cites this paper
• Nephronophthisis and Medullary Cystic Kidney Disease in Children

  2015cites this paper
• c-Myc Signalling in the Genetic Mechanism of Polycystic Kidney Disease

  2015cites this paper
• Regulation of the mRNA silencing activity of Bicaudal-C

  2015cites this paper
• Expression of Na+/H+ exchanger regulatory factor 1 in autosomal-dominant polycystic kidney disease

  2015cites this paper
• Aquaporin‐1 retards renal cyst development in polycystic kidney disease by inhibition of Wnt signaling

  2015cites this paper
• Vasopressin and disruption of calcium signalling in polycystic kidney disease

  2015cites this paper
• Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

  2015cites this paper
• Coordination of kidney organogenesis by Wnt signaling

  2014cites this paper
• Meckel-Gruber syndrome and the role of primary cilia in kidney, skeleton, and central nervous system development

  2014cites this paper
• Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis

  2014cites this paper
• Developmental signaling: does it bridge the gap between cilia dysfunction and renal cystogenesis?

  2014cites this paper
• Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum.

  2014cites this paper
• Primary Cilium Regulates CaV1.2 Expression Through Wnt Signaling

  2014cites this paper
• Kidney: polycystic kidney disease

  2014cites this paper
• Role of Wnt signaling in tissue fibrosis, lessons from skeletal muscle and kidney.

  2014cites this paper
• Mutations in ANKS6 cause a nephronophthisis-like phenotype with ESRD.

  2014cites this paper
• Downregulating hedgehog signaling reduces renal cystogenic potential of mouse models.

  2014cites this paper
• Wnt Signaling in Kidney Organogenesis

  2014cites this paper
• Strategies targeting cAMP signaling in the treatment of polycystic kidney disease.

  2014cites this paper
• Gpr48 Deficiency Induces Polycystic Kidney Lesions and Renal Fibrosis in Mice by Activating Wnt Signal Pathway

  2014cites this paper
• THE ROLE OF MACROPHAGES IN THE PROGRESSION OF POLYCYSTIC KIDNEY DISEASE

  2014cites this paper
• A New Therapeutic Strategy for Autosomal Dominant Polycystic Kidney Disease: Activation of AMP Kinase by Metformin

  2014cites this paper
• T-Cell Factor/ β -Catenin Activity is Suppressed Normally in Two Independent Models of Autosomal Dominant Polycystic Kidney Disease

  2014cites this paper
• Wnt signalling in kidney diseases: dual roles in renal injury and repair

  2013cites this paper
• Wnt and planar cell polarity signaling in cystic renal disease

  2013cites this paper
• Chapter 80 – Autosomal Dominant Polycystic Kidney Disease

  2013cites this paper
• Evidence that TMEM67 causes polycystic kidney disease through activation of JNK/ERK‐dependent pathways

  2013cites this paper
• Rational therapy for renal cell carcinoma based on its genetic targets.

  2013cites this paper
• Inversin modulates the cortical actin network during mitosis.

  2013cites this paper
• Health care resource utilization and expenditures in persons with autosomal dominant polycystic kidney disease

  2013cites this paper
• The Meckel syndrome protein meckelin (TMEM67) is a key regulator of cilia function but is not required for tissue planar polarity.

  2013cites this paper
• Functional aspects of primary cilia in signaling, cell cycle and tumorigenesis

  2013cites this paper
• Cell polarity and cystic kidney disease

  2013cites this paper
• Renal cystic disease: from mechanisms to drug development

  2013cites this paper
• Planar cell polarity (PCP) and Wnt signaling in renal disease

  2013cites this paper